Clearline Capital’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Clearline Capital’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-284,128	Closed	-$705K	–	149
2023 Q2	$705K	Hold	284,128	–	–	0.04%	95
2023 Q1	$415K	Sell	284,128 -3,800	-1%	-$7.06K	0.06%	91
2022 Q4	$559K	Sell	287,928 -30,863	-10%	-$33.8K	0.1%	100
2022 Q3	$124K	Hold	318,791	–	–	0.01%	131
2022 Q2	$191K	Hold	318,791	–	–	0.02%	124
2022 Q1	$281K	Sell	318,791 -35,161	-10%	-$44.7K	0.03%	116
2021 Q4	$725K	Buy	+353,952	New	+$540K	0.08%	101

Clearline Capital's ROIVW Position: Q3 2023 in Review

Clearline Capital sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 284,128 shares — an estimated $705K sold.

Clearline Capital first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $725K in Q4 2021. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

Clearline Capital reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
Clearline Capital sold 284,128 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $705K.
Clearline Capital first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
Clearline Capital's Roivant Sciences Ltd. Warrant position peaked at $725K in Q4 2021.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Clearline Capital's 13F filing for Q3 2023, filed 14 Nov 2023.